News & Articles

Fulfil your continuing professional development (CPD) requirements with help from SelectScience’s new accredited webinars

An international collaboration between the University of Bath and Universidad de los Andes has developed an integrated device for testing a water source

Recent findings show initial testing for three specific biomarkers may provide superior results over standard screening methods

Offered as part of a routine CBC with differential test, the hematology-based solution is intended to alert emergency department clinicians to sepsis or the possibility of sepsis earlier than any other indicator

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors

New Yumizen G coagulation analyzers and reagent range designed to suit any laboratory

Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher

The new system aims to deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput

The robust, easy-to-use system aims to boost patient care by combining many of the analytic strengths of a larger-volume instrument with the ease of a table-top analyzer

First-of-its-kind hematology-based test intended to alert emergency department clinicians to the risk of developing sepsis

Healthcare wearables company, Activinsights, commended for enterprise in Britain’s top business accolade

The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax

SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism

From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology

Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute

Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research

Study demonstrates that the test can add prognostic information on overall survival